Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer

BACKGROUND: Delays in the initiation of therapy among patients with early stage breast cancer (BC) can negatively affect outcomes. Patients treated with neoadjuvant systemic chemotherapy (NSC) usually display tumors with high‐risk features. Considering these high‐risk characteristics and the evidenc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: de Melo Gagliato, Debora, Lei, Xiudong, Giordano, Sharon H., Valero, Vicente, Barcenas, Carlos H., Hortobagyi, Gabriel N., Chavez‐MacGregor, Mariana
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Inc. 2020
Предметы:
Breast Cancer
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485349/
https://ncbi.nlm.nih.gov/pubmed/32431013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0744
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы